V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240001980 | 240010189 | 1.61 | 85.5 | 03 | 2018-12-12 | 2018-12-13 | ALL ALLR3: S/IR Cons Wk 5 | 01 | N | CYCLOPHOSPHAMIDE | 100601255 |
| 240002001 | 240010192 | 1.65 | 77.2 | Curative (C) | 2017-02-04 | 2017-02-07 | ALL Interim Guide 2019 Capizzi Interim Maintenance C | 02 | N | CARBOPLATIN + ETOPOSIDE | 101671093 |
| 240002008 | 240010194 | 1.58 | 76.8 | null | null | 2019-04-13 | AML MyeChild 01 FLA | N | null | CVP R | 100372179 |
| 240002033 | 240010199 | 1.64 | 30.6 | Palliative (P) | null | 2022-02-15 | AML MyeChild 01 FLA-Idarubicin | N | N | CISPLATIN + CYTARABINE + ETOPOSIDE | 101812728 |
| 240002034 | 240010200 | 1.68 | 66 | null | null | 2019-08-18 | DHAX - R | null | null | FLAIR TRIAL | 100494626 |
| 240002045 | 240010202 | 1.63 | 64 | Curative (C) | 2019-05-03 | 2019-05-05 | GDP | 02 | N | PEG INTERFERON | 101542718 |
| 240002053 | 240010204 | null | 80 | Palliative (P) | 2018-11-01 | 2018-11-01 | ALL ALLR3: S/IR Cons Wk 5 | 01 | N | IBRUTINIB | 100888154 |
| 240002074 | 240010208 | null | 78 | null | null | 2021-10-17 | FLAIR trial | null | null | CYCLOPHOSPHAMIDE | 100410732 |
| 240002082 | 240010209 | 0 | 30.6 | Curative (C) | null | 2020-05-17 | null | 02 | null | TRANSPLANT ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 100934477 |
| 240002093 | 240010210 | 1.68 | 84.3 | null | 2017-02-07 | 2017-02-07 | null | N | null | NOT MATCHED | 100488667 |
| 240002096 | 240010211 | 1.83 | 51.8 | null | null | 2020-09-08 | Alemtuz+Fludara+Melphalan RIC MUD | 01 | null | BENDAMUSTINE + POLATUZUMAB VEDOTIN + RITUXIMAB | 101337720 |
| 240002100 | 240010212 | 1.7 | 66.9 | null | 2016-06-19 | 2016-06-20 | BENDAMUSTINE + POLATUZUMAB VEDOTIN + RITUXIMAB | 02 | null | CNS LOW GRADE GLIOMA VINBLASTINE | 100747234 |
| 240002109 | 240010213 | 1.76 | 100.9 | 03 | 2019-06-13 | 2019-06-13 | null | 02 | null | CHLORAMBUCIL + RITUXIMAB | 100399769 |
| 240002134 | 240010215 | 1.58 | 78.5 | null | null | 2021-08-30 | Pentostatin | null | null | STS NON-RHABDO EPSSG 2005 VBL/MTX | 100183450 |
| 240002136 | 240010216 | 1.75 | 63.6 | null | 2021-07-10 | 2021-08-05 | Venetoclax | 02 | null | UKALL2011 | 101441200 |
| 240002152 | 240010218 | 1.62 | 62.2 | null | 2019-11-19 | 2019-11-21 | Triple / Double Intrathecal Therapy + hydrocortisone | 02 | null | CYTARABINE + DAUNORUBICIN | 100343792 |
| 240002153 | 240010219 | 1.82 | 70.6 | null | 2019-04-10 | 2019-04-15 | FLAG | 02 | null | BUSULFAN | 100732469 |
| 240002157 | 240010220 | 1.63 | 77.6 | Palliative (P) | null | 2020-09-09 | R GDP | null | null | GEMCITABINE + RITUXIMAB | 101846235 |
| 240002159 | 240010221 | 1.83 | 64.8 | null | 2016-12-21 | 2017-01-08 | null | N | null | RUXOLITINIB | 101722751 |
| 240002160 | 240010222 | 1.73 | null | Palliative (P) | 2016-06-08 | 2016-06-08 | Venetoclax | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN | 100300505 |
| 240002171 | 240010226 | 1.65 | 112.4 | Curative (C) | 2020-11-08 | 2020-11-08 | Clofarabine + Cytarabine | 02 | N | TRANSPLANT ALEMTUZUMAB + CYCLOPHOSPHAMIDE (+/- TBI) | 101783614 |
| 240002174 | 240010227 | 1.83 | 79.6 | null | 2021-04-01 | 2021-04-07 | null | 02 | null | DABRAFENIB | 100903268 |
| 240002194 | 240010231 | 0 | 30 | null | null | 2021-01-12 | Ixazomib + Lenalidomide | null | null | AML DOWNS ADE | 100164261 |
| 240002199 | 240010232 | 1.65 | 45.3 | null | null | 2022-02-04 | CHLORAMBUCIL + RITUXIMAB | null | null | ANTI-THYMOCYTE GLOBULIN + BUSULFAN + FLUDARABINE | 101817798 |
| 240002206 | 240010233 | 1.57 | 10.6 | null | null | 2021-01-20 | null | null | null | AML MYECHILD 01 ARM E MAC HSCT | 101859904 |
| 240002216 | 240010234 | 1.72 | 17.3 | null | 2020-08-21 | 2020-12-29 | Chlorambucil | null | N | AML16 TRIAL | 100326439 |
| 240002222 | 240010235 | 1.85 | 58.4 | Curative (C) | null | 2021-12-20 | IPILIMUMAB + NIVOLUMAB | 99 | N | AML MYECHILD 01 IT CYT | 101586362 |
| 240002224 | 240010236 | 1.84 | 81.5 | null | 2021-03-22 | 2021-03-24 | RUXOLITINIB | 02 | null | CYCLOPHOSPHAMIDE + FLUDARABINE | 100606828 |
| 240002228 | 240010237 | 1.58 | 59.6 | null | 2018-11-16 | 2019-11-14 | null | 02 | null | NOT MATCHED | 101252329 |
| 240002241 | 240010238 | 0 | 55 | null | 2019-07-13 | 2019-07-13 | Rituximab + Venetoclax | 02 | null | CNS HGG TEMOZOLOMIDE MAINTENANCE | 100540022 |
| 240002248 | 240010239 | 1.65 | 84.4 | 03 | 2016-06-01 | 2016-06-08 | null | 02 | N | RUXOLITINIB | 100581147 |
| 240002253 | 240010240 | 1.57 | 72.9 | Curative (C) | 2018-08-06 | 2018-09-16 | null | null | null | CLADRIBINE | 100254580 |
| 240002260 | 240010241 | null | 9.95 | Curative (C) | 2018-12-31 | 2019-01-14 | FCR Oral - Cycle 2 onwards | null | null | CARMUSTINE + THIOTEPA | 100126269 |
| 240002282 | 240010244 | 1.82 | 109.4 | Curative (C) | 2019-09-20 | 2019-09-23 | ATG + Busulfan + Fludarabine | 02 | null | AML MYECHILD 01 IT CYT | 101256721 |
| 240002292 | 240010246 | 1.75 | 91.1 | Disease modification (D) | null | 2019-08-18 | ANAGRELIDE | null | null | CHLORAMBUCIL + OBINUTUZUMAB | 100628748 |
| 240002294 | 240010247 | null | null | Curative (C) | 2018-07-14 | 2018-08-08 | null | null | N | CYTARABINE + ETOPOSIDE + IFOSFAMIDE + RITUXIMAB | 100792389 |
| 240002298 | 240010248 | 1.63 | 64 | Curative (C) | 2021-09-28 | 2021-10-05 | DABRAFENIB | 02 | null | CNS LGG2004 03 VINC + CARBO | 100054492 |
| 240002310 | 240010249 | 1.85 | 75 | Curative (C) | 2021-12-27 | 2021-12-27 | null | N | null | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE + RITUXIMAB | 100045573 |
| 240002316 | 240010251 | 1.58 | 17 | null | 2020-10-04 | 2020-11-20 | null | 02 | null | CISPLATIN + GEMCITABINE | 100992913 |
| 240002341 | 240010253 | 1.74 | 81.7 | Disease modification (D) | null | 2019-05-26 | CYCLOPHOSPHAMIDE + RITUXIMAB | null | null | TRANSPLANT ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 100552467 |
| 240002345 | 240010255 | 0 | 78.2 | Curative (C) | 2020-11-17 | 2020-12-16 | Melphalan IV High dose | 02 | null | GEMCITABINE + VINORELBINE | 100710683 |
| 240002365 | 240010259 | 1.63 | 100.4 | null | 2016-08-23 | 2016-09-01 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | null | FLAIR TRIAL | 101217456 |
| 240002374 | 240010261 | 1.83 | 95 | Curative (C) | null | 2020-01-01 | null | null | N | VENETOCLAX | 100187681 |
| 240002384 | 240010262 | 1.8 | 94.6 | null | 2020-03-27 | 2020-04-01 | AML MyeChild 01 IT Cyt | 02 | null | ALL UKALL2011 MAINTENANCE | 101289571 |
| 240002386 | 240010263 | 1.83 | 72.9 | Curative (C) | 2017-12-25 | 2017-12-25 | CODOX M | Y | N | AML16 TRIAL | 100377782 |
| 240002391 | 240010264 | 1.79 | 102.8 | null | 2020-11-17 | 2020-11-18 | ALL UKALL 2011 HD MtxB (Protocol M) | 02 | null | TRANSPLANT ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 101179262 |
| 240002393 | 240010265 | 1.77 | 76.6 | Curative (C) | 2019-08-02 | 2019-08-04 | Venetoclax | 02 | null | DOCETAXEL + GEMCITABINE | 100445404 |
| 240002408 | 240010266 | 1.65 | 63.1 | null | null | 2019-08-21 | Bortezomib +/- Dexamethasone | null | null | LENALIDOMIDE | 101831406 |
| 240002418 | 240010269 | 1.77 | 73.2 | 03 | 2021-05-17 | 2021-07-20 | null | N | N | RUXOLITINIB | 100515222 |
| 240002421 | 240010270 | 1.62 | 57.4 | Disease modification (D) | 2019-06-01 | 2019-06-25 | Venetoclax | 02 | null | FLAIR TRIAL | 100148329 |